| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/28/2001 | EP1086699A1 Process for producing composite preparation containing nucleic acid |
| 03/28/2001 | EP1086692A2 Estrogen agonists and antagonists for multiple indications |
| 03/28/2001 | EP1086239A1 Formulations for electroporation |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086219A2 Proteins regulating gene expression |
| 03/28/2001 | EP1086215A2 Preparation and use of superior vaccines |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086107A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086105A1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086099A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086085A1 INHIBITORS OF p38 |
| 03/28/2001 | EP1086080A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | EP1085905A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/28/2001 | EP1085902A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 03/28/2001 | EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085892A2 Vaccination strategy to prevent and treat cancers |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP1085876A1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 03/28/2001 | EP1085872A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-$g(k)B |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1085811A1 Broad specificity dna damage endonuclease |
| 03/28/2001 | EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 03/28/2001 | EP0767800B1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289331A Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289323A Matrix metalloproteinase inhibitors |
| 03/28/2001 | CN1289322A Hydroxamic and carboxylic acid derivatives |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
| 03/28/2001 | CN1288950A Preparation and application of monocloning antibody based on DNA immunity |
| 03/28/2001 | CN1288897A Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
| 03/28/2001 | CN1288890A Water soluble taxad alcohol derivative |
| 03/28/2001 | CN1288885A Alkylating method of hindered sulfonic acid |
| 03/28/2001 | CN1288755A Pure beta ray corrying safe microball and its preparation |
| 03/28/2001 | CN1288729A Freeze dried lentinan holoside powder injecta and its preparation |
| 03/28/2001 | CN1288723A Nanometer-size realgar and its preparation |
| 03/28/2001 | CN1063758C Sulphur-35 labeled single clone antibody and its preparing method |
| 03/28/2001 | CN1063654C Cancer treating granule |
| 03/28/2001 | CN1063652C Oral liquor for mannary gland disease |
| 03/28/2001 | CN1063651C Decoction for treating cancer |
| 03/28/2001 | CN1063648C Chinese medicinal preparation for treating cancer |
| 03/28/2001 | CN1063630C Surface-modified anticancer nanopartiles |
| 03/27/2001 | US6207842 Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives |
| 03/27/2001 | US6207832 Camptothecin analogs and methods of preparation thereof |
| 03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
| 03/27/2001 | US6207815 Dna coding for chimeric heavy chain or antigen binding fragment produced by specific cell lines; combines with high molecular weight, tumor-associated sialylated glycoprotein antigen light chain; diagnosis; imaging |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207716 Non-steroidal ligands for the estrogen receptor |
| 03/27/2001 | US6207700 Aministering carboxylic acid secondary amide derivative containing indole system which is selective for inhibition of cyclooxygenase-2 for cancer therapy in warm blooded vertebrate animal |
| 03/27/2001 | US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection |
| 03/27/2001 | US6207690 Treating tumor by administering therapeutically effective amount of triglitazone compound |
| 03/27/2001 | US6207669 In treatment of cancer and psoriasis |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/27/2001 | US6207660 Texaphyrin conjugates and uses thereof |
| 03/27/2001 | US6207649 Nucleoside analogs and uses in treating disease |
| 03/27/2001 | US6207648 Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy |
| 03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207403 Kinesin motor modulators derived from the marine sponge Adocia |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207195 Sodium 4-phenylbutyrate in solid nanosphere formed by coacervation of a polycation, i.e., a protein and a polyanion, i.e., a nucleic acid; treatment of cystic fibrosis |
| 03/27/2001 | US6207170 Extract from plasma membrane form malignant white blood cells |
| 03/27/2001 | US6207156 Specific antibodies and antibody fragments |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207150 Variants of thymidine kinase, nucleic acids encoding them, and methods of using them |
| 03/27/2001 | US6207147 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 03/27/2001 | US6207133 Anti-tumoral therapy agent containing a contrast agent |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2148822C Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 03/27/2001 | CA2091562C Indole derivatives useful in psychotherapeutics |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/27/2001 | CA2046916C Methods and compositions for treatment of cancer using oligonucleotides |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |